Back to results
US 2026/0083860 A1Published application
Compositions and methods for genome editing
AssigneePoseida Therapeutics, Inc.
InventorsOscar ALVAREZ, Ming-Yue LEE, Blair B. MADISON
Life of this patent
Estimating the term…
Abstract
Disclosed are methods and compositions for functional genetic modifications at selected sites. Also provided are cell populations, which comprise targeted integration of one or more exogenous polynucleotides, and/or indels at one or more selected gene loci.
Claims20
A polypeptide comprising the amino acid sequence of SEQ ID NO:
- 35.
A method of modifying a target sequence in the genome of a plurality of cells comprising introducing to a population of unmodified cells a composition comprising:
- a) a polypeptide comprising the amino acid sequence of SEQ ID NO:
- 35, or a polynucleotide encoding the polypeptide of SEQ ID NO:
- 35;
- and
- b) at least one guide RNA (gRNA),
- thereby generating a modification at the target sequence in the genome, and
- wherein 1.1-fold to 50-fold of the plurality of cells comprise the modification at the target sequence in the genome in comparison to a plurality of modified cells introduced with a composition comprising a polypeptide comprising the amino acid sequence of SEQ ID NO:
- 10 or a polynucleotide encoding the polypeptide of SEQ ID NO:
- 10.
6 more elements
Dependencies are inferred from the claim text.